JH

Jayalekshmi Haripriyan

Active Director Director DIN 10750728
DIN 10750728 First appointment Aug 2024 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayalekshmi Haripriyan

Data last updated:

Jayalekshmi Haripriyan is a Director at Trita Biotech Private Limited (since 2024). The company operates in Wood.

DIN 10750728
Primary Designation Director
Industry Wood
First Appointment 22 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trita Biotech Private Limited U20299KL2024PTC089310
Director22 Aug 20242024Active

Board colleagues of Jayalekshmi Haripriyan

NameDINCompanyDesignation
Maneesh Mailankot10750726Trita Biotech Private LimitedManaging Director
Pranav Maneesh10750727Trita Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Trita Biotech Private Limited
Premium access

Shareholding and investment profile for Jayalekshmi Haripriyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayalekshmi Haripriyan

Jayalekshmi Haripriyan currently holds 1 directorship: Trita Biotech Private Limited (Director, since 22 Aug 2024).

Jayalekshmi Haripriyan was first appointed on 22 Aug 2024 as Director at Trita Biotech Private Limited.

The current boards of Jayalekshmi Haripriyan's companies include Maneesh Mailankot (Trita Biotech Private Limited), Pranav Maneesh (Trita Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available